SEC Form 4 · accession 0001213900-15-009392
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Berelowitz
Director
Period of report
Dec 9, 2015
Accepted (ET)
Dec 10, 2015 · 12:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 9, 2015 | S | 700 | $9.44 | D | 22,896 | D |
Table II — derivative securities
No Table II lines on this filing.